Points of View
More Artificial Intelligence Research
Novartis partners with Microsoft to build AI solutions—showing pharma firms why they must look to partnerships for success
Pharma’s executives and artificial intelligence (AI) project leaders will undoubtedly have noticed the partnership between Microsoft and Novartis to leverage AI throughout the industry ecosystem and value chain. The competition to realize AI’s potential in pharma is already fierce—modeling disease, drug discovery, and diagnosis—before considering the challenges that the industry’s grappling with: siloed functions and data, cultural barriers, and ongoing operational transformations. If you’re late to the AI game in pharma, don’t panic, but the time to act is now. If you’re swift, you will find plenty of potential partners with expertise out there and plenty of value propositions to realize by tackling the industry’s most pressing challenges.
Sign in or register an account to access HFS' Content
Create an account